Analysts See $0.22 EPS for Medidata Solutions, Inc. (MDSO) as of July, 17

June 27, 2018 - By Gwen Gough

Medidata Solutions, Inc. (NASDAQ:MDSO) Corporate Logo
During 2018 Q1 the big money sentiment decreased to 0.95. That’s change of 0.76, from 2017Q4’s 1.71. 36 investors sold all, 74 reduced holdings as Medidata Solutions, Inc. ratio dropped. 76 grew stakes while 28 funds acquired stakes. Funds hold 62.26 million shares thus 1.96% more from 2017Q4’s 61.06 million shares.
New Mexico Educational Retirement Board accumulated 16,100 shs. Yorktown Mngmt Rech Inc has 4,600 shs for 0.09% of their capital. Pub Employees Retirement System Of Ohio, Ohio-based fund reported 119,827 shs. Great West Life Assurance Can stated it has 33,440 shs. Blackrock has invested 0.02% in Medidata Solutions, Inc. (NASDAQ:MDSO). Disciplined Growth Mn reported 1.15% stake. Millennium Ltd Liability Company has 14,697 shs. Swiss Savings Bank has 0.01% invested in Medidata Solutions, Inc. (NASDAQ:MDSO) for 101,900 shs. Delta Asset Mgmt Limited Company Tn stated it has 0% in Medidata Solutions, Inc. (NASDAQ:MDSO). Goldman Sachs Inc holds 0.01% or 870,609 shs. 1.38 million were reported by Glob Thematic Prns Limited Liability. Us Bancorporation De holds 8,312 shs. Secor Capital Advsr Limited Partnership has 94,651 shs for 0.49% of their capital. Stratos Wealth Ptnrs Ltd holds 0% or 80 shs. Kornitzer Capital Mngmt Ks invested 0.17% of its capital in Medidata Solutions, Inc. (NASDAQ:MDSO).

Medidata Solutions, Inc. registered $6.22 million net activity with 0 insider purchases and 12 insider sales since January 19, 2018. On Monday, May 21 Bergmann Rouven sold $226,560 worth of Medidata Solutions, Inc. (NASDAQ:MDSO). de Vries Glen Michael sold $1.88 million worth of Medidata Solutions, Inc. (NASDAQ:MDSO) on Friday, March 9. On Wednesday, April 25 Otner Michael I. sold $728,170 worth of Medidata Solutions, Inc. (NASDAQ:MDSO). On Monday, June 4 3,630 shs were sold by TAYLOR ROBERT, worth $285,681.

Medidata Solutions, Inc. (NASDAQ:MDSO)’s earnings release is anticipated by WallStreet on July, 17, Zacks reports. Analysts forecast 22.22 % diference or $0.22 from the $0.18 EPS from 2017. If reported the P/E will be 90.26 with $13.02M profit. After $0.24 EPS report previous quarter, Wall Street now predicts -8.33 % negative EPS growth of Medidata Solutions, Inc.. The stock increased 0.12% or $0.1 during the last trading session, touching $79.43.Medidata Solutions, Inc. has volume of 26,162 shares. Since June 27, 2017 MDSO has risen 4.39% and is uptrending. MDSO underperformed the S&P500 by 8.18%.

Medidata Solutions, Inc. (NASDAQ:MDSO) Ratings Coverage

Total analysts of 10 have positions in Medidata Solutions (NASDAQ:MDSO) as follows: 6 rated it a “Buy”, 0 with “Sell” and 4 with “Hold”. The positive are 60%. Since January 3, 2018 according to StockzIntelligence Inc Medidata Solutions has 14 analyst reports. On Thursday, May 31 the rating was maintained by Deutsche Bank with “Buy”. On Thursday, February 8 the stock of Medidata Solutions, Inc. (NASDAQ:MDSO) has “Hold” rating given by Jefferies. On Thursday, May 10 the stock of Medidata Solutions, Inc. (NASDAQ:MDSO) has “Buy” rating given by Dougherty. The company rating was downgraded by Morgan Stanley on Monday, May 21. On Wednesday, January 3 KeyBanc Capital Markets maintained Medidata Solutions, Inc. (NASDAQ:MDSO) rating. KeyBanc Capital Markets has “Buy” rating and $88.0 target. On Tuesday, June 12 the rating was maintained by Piper Jaffray with “Buy”. On Wednesday, June 13 the stock of Medidata Solutions, Inc. (NASDAQ:MDSO) earned “Buy” rating by Deutsche Bank. On Thursday, February 8 the rating was maintained by RBC Capital Markets with “Hold”. On Wednesday, May 23 Piper Jaffray maintained Medidata Solutions, Inc. (NASDAQ:MDSO) with “Buy” rating. The stock rating was maintained by SunTrust with “Buy” on Monday, January 22.

Medidata Solutions, Inc. provides cloud solutions for life sciences worldwide.The firm is valued at $4.70 billion. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development.The P/E ratio is 107.48. The companyÂ’s platform solutions includes Plan Study that addresses the areas to ensure optimal study design, grant development and negotiation, and investigator payments; and Support Sites, which provides robust risk management, reduced source document verification, real-time monitoring, on-time, accurate payments.

More recent Medidata Solutions, Inc. (NASDAQ:MDSO) news were released by Businesswire.com, Seekingalpha.com and Streetinsider.com. The first one has “Clinical Research Can Now Be Truly Patient-Centric By Quantifying Patient Burden with Medidata” as a title and was released on June 25, 2018. The next is “Medidata Solutions acquires SHYFT Analytics for $195M in cash” on June 12, 2018. And last was released on May 31, 2018, called “Medidata Solutions (MDSO) PT Raised to $85 at Deutsche Bank”.

Medidata Solutions, Inc. (NASDAQ:MDSO) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: